Shares of Henry Schein Inc. (NASDAQ:HSIC) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $182.30 and last traded at $182.26, with a volume of 96,296 shares traded. The stock had previously closed at $180.72.

Several analysts recently issued reports on the stock. Leerink Swann reiterated a “hold” rating on shares of Henry Schein in a research report on Thursday, May 5th. Zacks Investment Research lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Tuesday, April 26th. Vetr upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $176.75 price target on the stock in a research report on Monday, March 21st. Credit Suisse Group AG assumed coverage on shares of Henry Schein in a research report on Tuesday, March 15th. They set a “neutral” rating and a $170.00 price target on the stock. Finally, Robert W. Baird increased their price target on shares of Henry Schein from $167.00 to $175.00 in a research report on Wednesday, March 16th. Eight analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $155.37.

The stock’s 50-day moving average is $175.73 and its 200-day moving average is $166.43. The firm has a market capitalization of $14.85 billion and a PE ratio of 30.96.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, May 3rd. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.02. The business earned $2.70 billion during the quarter, compared to the consensus estimate of $2.66 billion. During the same period last year, the firm earned $1.28 EPS. The business’s revenue for the quarter was up 10.1% on a year-over-year basis. On average, analysts forecast that Henry Schein Inc. will post $6.63 EPS for the current fiscal year.

In related news, EVP Gerald A. Benjamin sold 9,991 shares of the company’s stock in a transaction that occurred on Thursday, June 2nd. The shares were sold at an average price of $175.08, for a total transaction of $1,749,224.28. Following the sale, the executive vice president now owns 54,885 shares of the company’s stock, valued at approximately $9,609,265.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Peter M. Mccarthy sold 1,158 shares of the company’s stock in a transaction that occurred on Thursday, May 12th. The stock was sold at an average price of $171.75, for a total transaction of $198,886.50. Following the sale, the insider now directly owns 12,285 shares in the company, valued at approximately $2,109,948.75. The disclosure for this sale can be found here.

Other hedge funds have recently bought and sold shares of the company. BNP Paribas Arbitrage SA raised its stake in Henry Schein by 340.1% in the fourth quarter. BNP Paribas Arbitrage SA now owns 15,152 shares of the company’s stock worth $2,397,000 after buying an additional 11,709 shares during the period. Bronfman E.L. Rothschild L.P. purchased a new stake in Henry Schein during the fourth quarter worth $2,086,000. Pittenger & Anderson Inc. raised its stake in Henry Schein by 9.8% in the fourth quarter. Pittenger & Anderson Inc. now owns 25,431 shares of the company’s stock worth $4,023,000 after buying an additional 2,280 shares during the period. Marshall Wace LLP purchased a new stake in Henry Schein during the fourth quarter worth $3,743,000. Finally, Eaton Vance Management raised its stake in Henry Schein by 3.8% in the fourth quarter. Eaton Vance Management now owns 117,100 shares of the company’s stock worth $18,524,000 after buying an additional 4,324 shares during the period.

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.